Common side effects include nausea, vomiting, and diarrhea, which are often mild and tend to decrease over time as the body adjusts to the medication
On the other hand, Wegovy contains the active ingredient semaglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist
Liraglutide and semaglutide are GLP-1 RAs whereas tirzepatide is a combined agonist to both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors
Lipid panels: These reflect metabolic shifts as weight and insulin sensitivity change, and clinicians often recheck lipids within 8 to 12 weeks of a dose change to capture meaningful movement
Many of these drugs are meant for diabetic patients, yet theyre being promoted for weight loss or general well-being. The semaglutide craze was already hard to miss, but now Im seeing companies sell Metformin with claims that it will make you feel better or have more energy